Fundz

Myome Secures $23M In Series B Funding To Deliver Clinical Whole Genome Insights To Help Families Manage Risk For Inherited Diseases

PRIVATEJun 21, 2022

Amount Raised

$23 Million

Round Type

Series B

Menlo ParkBiotechnologyFinancial ServicesSoftwareHealth CareLending And Investments

Description

MyOme, a clinical whole genome platform analysis company, today announced that the company has raised $23 million in an oversubscribed series B financing round led by Healthcare Venture Partners, bringing the total raised to over $36M. MyOme plans to use the funds to begin commercialization of their clinical whole genome analysis platform technology and clinical reports to health systems. The MyOme platform will help families understand and manage their risk for inherited disease.

Quick answer

My Ome raised $23 Million in a Series B round, dated June 21, 2022. My Ome is based in Menlo Park, California, United States.

How much did My Ome raise?
My Ome raised $23 Million in a Series B round on June 21, 2022.
What does My Ome do?
The oversubscribed series B financing led by Healthcare Venture Partners, added SoftBank Corp. and Natera to existing investors– Sequoia Capital, Foresite Capital, Founders Fund, among othersMENLO PARK, Calif., June 21,..
Where is My Ome based and how big is it?
My Ome is based in Menlo Park, California, United States. Fundz records about 99 employees.

Source: Fundz verified event record.

Who else raised in Financial Services and Lending And Investments around the same time

Companies in the same sectors as My Ome that raised within 45 days of this round, from Fundz verified event records.

  • Sympatic raised an undisclosed amount (Pre-Seed) on August 4, 2022.
  • KuCoin raised $10M (Corporate Round) on July 21, 2022.
  • Quavo raised $3M on July 20, 2022.
  • Medical Microinstruments raised $75M (Funding Round) on July 20, 2022.
  • Quavo raised an undisclosed amount (Funding Round) on July 19, 2022.
  • Jakaverse raised $3M (Series A) on July 18, 2022.

Who to call at My Ome, and when

A new round usually means My Ome is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day My Ome raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at My Ome, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at My Ome. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

My Ome

Location

Menlo Park, California, United States

About

The oversubscribed series B financing led by Healthcare Venture Partners, added SoftBank Corp. and Natera to existing investors– Sequoia Capital, Foresite Capital, Founders Fund, among othersMENLO PARK, Calif., June 21, 2022 /PRNewswire/ -- MyOme, a clinical whole genome platform analysis company, today announced that the company has raised $23 million in an oversubscribed series B financing round led by Healthcare Venture Partners, bringing the total raised to over $36M. The MyOme platform will help families understand and manage their risk for inherited disease. MyOme was founded by leaders in the field of genomics, including Matthew Rabinowitz, co-founder of Natera. MyOme is at the forefront of developing clinical applications to support families of all ethnicities." MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment My Ome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for My Ome's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

My Ome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.